Healthcare -
Biotechnology - NASDAQ - US
$ 0.7352
-3.14 %
$ 40.5 M
Market Cap
-0.42
P/E
PRLD - OPERATING EXPENSES
Operating Expenses PRLD - Prelude Therapeutics Incorporated
132 M
LAST VALUE
7.84%
2 YEAR CAGR
54.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR